This page is for informational purposes only and does not replace medical advice. If you’re experiencing any of the symptoms below, please see a gynaecologist or oncologist for proper evaluation. As of 2026, the information reflects current clinical guidance.

Ovarian cancer rarely announces itself. There’s no dramatic pain, no single red flag most women recognise right away. Instead, it shows up as bloating, a bit of pelvic discomfort, or feeling full after a small meal, things most of us would blame on stress or a bad lunch. That’s exactly why it’s often called a silent disease, and why understanding these early ovarian cancer symptoms can genuinely change the outcome.

What are the early symptoms of ovarian cancer?

The most commonly reported early symptoms are persistent bloating, pelvic or abdominal pain, feeling full quickly while eating, and needing to urinate more often or urgently. What makes these tricky isn’t the symptoms themselves. It’s the word “persistent.” A single day of bloating means nothing. Bloating that sticks around for two to three weeks, especially alongside one or two of the other signs, is worth getting checked.

Some women also notice unexplained changes in bowel habits, fatigue that doesn’t improve with rest, or unintended weight loss. Back pain and pain during intercourse can show up too, though these tend to appear a bit later.

None of these symptoms is unique to ovarian cancer on their own. A stomach bug causes bloating. Stress causes fatigue. That overlap is precisely the problem.

Why these symptoms get missed so often

Most of these signs mimic everyday digestive or menstrual complaints. A woman with bloating and a full feeling after meals is far more likely to be told it’s IBS, acid reflux, or “just hormones” than to be sent for an ovarian workup. Doctors aren’t wrong to consider common causes first. But when symptoms don’t resolve on their own timeline, that’s the signal to push further.

Only about 22 per cent of ovarian cancer cases are caught while still confined to the ovary. The rest are found after the disease has already spread, largely because both patients and, at times, doctors attribute the early signs to something more routine. This single gap, vague symptoms leading to delayed evaluation, is the biggest reason ovarian cancer has a lower survival rate than cancers like breast cancer, which has a clear screening tool in mammography.

What causes ovarian cancer

There’s no single cause, but a few factors clearly raise risk. Inherited mutations in the BRCA1 and BRCA2 genes are among the strongest, and they’re relevant to more than just risk. Tumours linked to these mutations often respond well to a class of targeted drugs called PARP inhibitors, which is one reason genetic testing at diagnosis matters, not just for family history purposes.

Age is another factor. Risk rises after menopause, and most cases are diagnosed in women over 50. A family history of ovarian, breast, or colorectal cancer, endometriosis, and never having been pregnant are also associated with somewhat higher risk. None of these guarantees anything. They simply shift the odds enough that awareness matters more for some women than others.

How is ovarian cancer diagnosed?

There’s no reliable population-wide screening test for ovarian cancer, which is different from how breast or cervical cancer works. According to the American Cancer Society, if a doctor suspects something based on symptoms, the usual next steps are a pelvic exam, a transvaginal ultrasound, and a CA-125 blood test. 

CA-125 gets mentioned a lot, so it’s worth being clear about what it actually tells you. It can be elevated with ovarian cancer, but it also rises with completely unrelated, non-cancerous conditions, and some ovarian cancers don’t raise it at all. It’s a supporting piece of the picture, not a standalone diagnostic test. If imaging and bloodwork raise concern, a biopsy confirms the diagnosis.

What are the stages of ovarian cancer?

Once diagnosed, staging tells you how far the cancer has spread and shapes everything about treatment. Stage I means the cancer is confined to one or both ovaries. Stage II means it has reached nearby pelvic organs. Stage III means it has spread beyond the pelvis to the lining of the abdomen or nearby lymph nodes. Stage IV means it has reached distant organs.

Survival is closely tied to stage at diagnosis. In the United States, five-year survival for localised disease sits around 92 per cent, compared to roughly 32 per cent once the cancer has spread to distant organs. That gap is the entire argument for taking early symptoms seriously rather than waiting them out.

Ovarian cancer treatment in India

Treatment typically combines surgery to remove as much of the tumour as possible with chemotherapy, and increasingly, targeted therapy for patients whose tumours carry specific mutations like BRCA1 or BRCA2. The right combination depends on stage, tumour type, and overall health, which is why a personalised plan matters more than a standard protocol.

Dr Aditya Sarin, a medical oncologist at Sir Ganga Ram Hospital, New Delhi, offers genetic testing and biomarker-driven treatment planning for ovarian cancer patients, so decisions around chemotherapy versus targeted therapy are based on the tumour’s actual biology rather than a one-size-fits-all approach. If you’ve already received a diagnosis elsewhere and want another set of eyes on your treatment plan, a second opinion is often worth the conversation, particularly for a cancer where treatment choices vary this much by individual case.

The takeaway

Ovarian cancer doesn’t come with an obvious warning sign, which puts the responsibility on paying attention to what’s persistent versus what’s passing. Bloating, pelvic discomfort, and early fullness that stick around for weeks aren’t things to sit on. If something feels off in your body and doesn’t resolve, book a consultation and have it checked properly.